科华生物 (002022)
SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 51434.82
- Circulating A-Shares(W): 51425.07
- Earnings Per Share(RMB): -0.4521
- Net Assets Per Share(RMB): 6.0277
- Operating Revenue(W RMB): 119126.06
- Total Profit(W RMB): -25175.38
- Net Profit Attributable to Parent(W RMB): -23253.28
- Net Profit Growth Rate(%): -90.38
- Weighted Return on Equity(%): -7.1600
- Operating Cash Flow Per Share(RMB): -0.0470
- Undistributed Profit Per Share(RMB): 4.2966
- Capital Reserve Per Share(RMB): 0.4451
2. Main Business
The main business covers:
- Research, production, and sales of in vitro diagnostic reagents
- Research, production, and sales of medical testing instruments
3. Company Basic Information
- Company Name: Shanghai Kehua Bioengineering Co., Ltd.
- Listing Date: 2004-07-21
- Industry: Pharmaceutical Manufacturing
- Address: No. 1189, Qinzhou North Road, Xuhui District, Shanghai
- Website: www.skhb.com
- Company Profile: The company was established as a joint-stock company by the initiators including the former Employee Shareholding Association of Shanghai Kehua Bioengineering Co., Ltd., Tang Weiguo, Sha Liwu, Xu Xiande, Shanghai Keshen Industrial Co., Ltd., and 47 other natural persons, approved by the Shanghai Municipal Government Document Hufu Tigaishan (1998) No. 065. The issuer was established on November 23, 1998, with a business registration number of 3100001005388, and the total share capital before issuance was 50.75 million shares.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Zhuhai Baolian Investment Holding Co., Ltd. | General Legal Person | 7014.72 | 13.64 |
| 2 | Xi'an Zhitong Benyi Enterprise Management Partnership (Limited Partnership) | General Legal Person | 2571.59 | 5.00 |
| 3 | Shanghai Puzhen Private Fund Management Co., Ltd. - Puzhen Ruoyu No. 2 Private Securities Investment Fund | Private Securities Investment Fund | 547.00 | 1.06 |
| 4 | Yongying CSI All Share Medical Devices Traded Open-End Index Securities Investment Fund | Fund | 317.32 | 0.62 |
5. Concept Sectors
- Convertible Bonds
- Biological Vaccines
- Gene Concept
- Hepatitis Concept
- Pet Economy
- Foreign Background
- Consecutive Losses
- Micro and Small Cap Stocks
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information
